The World Health Organization (WHO) has announced the launch of a new platform providing free cancer medicines to children in low- and middle-income countries.
On December 14, the delivery of the hepatitis C drug Sofosbuvir-400mg, allocated by the Egyptian government as humanitarian aid to our country, resumed.
Since the beginning of the year, the Committee for the Development of Competition and Consumer Protection has revealed price overstatement when selling medicines in 473 pharmacies, the press service of the department reported.
The Committee for the Development of Competition and Consumer Protection instructed five manufacturers to re-register their dietary supplements for dehydration as medicines. The process of removing them from retail chains has also already begun.
The Sanitary and Epidemiological Committee of Uzbekistan has instructed to withdraw the syrup "Rinotin Kids" from all pharmacies in the country.
In the first quarter of this year, the pharmaceutical company produced 1 trillion 157 billion soums of drugs and medicines in Uzbekistan, Sevara Tolaganova, the head of the information service of the AOKA Agency for the Development of Pharmacy Network, announced at the briefing. During this period, pharmaceutical manufacturers shipped $37 million worth of products abroad and mastered $25 million of investments in 17 projects.
Another batch of Sofosbuvir-400mg anti-hepatitis C drug has been delivered to Tashkent from Egypt.
The sixth batch of the drug Sofosbuvir-400mg against hepatitis C in the amount of 6,720 units was delivered to Tashkent from Egypt.
The fifth batch of the drug Sofosbuvir-400mg against hepatitis C in the amount of 6,720 units was delivered to Tashkent from Egypt.
The fourth batch of the drug Sofosbuvir-400mg against hepatitis C in the amount of 6,720 units was delivered to Tashkent from Egypt.
